ARCHIVES

FDA, NCI, Congress Shape Pediatric Drug Development Proposals

This article is from The Cancer Letter archive.

Vol. 29 No. 15 | April 11, 2003

Download PDF Visit The Full Archive

Related Articles

New Year Sees Growing Attacks On Cancer Program; Critics Repeat Untrue Charges, OMB Continues

January 3, 1975

Women Surgeons: We Need Answers On Tamoxifin Now

May 13, 1994

NCI Cooperative Group Clinical Trials Approved

September 24, 2010

Science Policy: Stem Cell Research Guidelines Formalize NIH Funding Polices

December 3, 1999

ASCO Defines Clinically Meaningful Outcomes

April 25, 2013

Wender Named ACS Chief Cancer Control Officer

August 9, 2013